Company LPS-Biosciences is an innovative Biotech SME established in 2011 with strong expertise in bacterial endotoxins and structural analysis with... Read more
A March 2023 study suggests that LPS can reduce methamphetamine cravings by modulating microglia, the brain’s primary immune cells, highlighting... Read more
We are happy to welcome Lowenn Nivon, as our new Marketing and Business Development intern at LPS-BioSciences. Lowenn is a... Read more
We are happy to welcome Thibault MERCEY as Managing Director and Deputy CEO at LPS-Biosciences. He is in charge of... Read more
Itchy skin, psoriasis and LPS derived from gut microbiota seems to be entirely different topics. However, a recent scientific report... Read more
In 2020, 98.5% of confirmed human zoonotic disease cases were associated with Gram-negative bacteria, meaning that 98.5% of these cases... Read more
March 18th, 2024. Frederic CAROFF, CEO at LPS-BIOSCIENCES participated to Bio Europe Spring Barcelona ! 🦎🇪🇸 Participating to a BIO... Read more
2023 is over and has been successful! 2024 will be even better with upcoming new features:
Company LPS-Biosciences is an innovative Biotech SME established in 2011 with strong expertise in bacterial endotoxins and structural analysis with... Read more
